| Issue Date | Title | Author(s) |
| 2021-02-04 | Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-κB pathway in the pathogenesis of cancer | Gupta, G; Kazmi, I; Al-Abbasi, FA; Singh, Y; S, R; Rani, S; Mishra, A; Prasher, P; Jha, NK; Thangavelu, L; Dureja, H; Singh, SK; Bhatt, S; Chellappan, DK; Dua, K |
| 2022-03-21 | Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora | Alharbi, KS; Singh, Y; almalki, WH; Rawat, S; Afzal, O; Altamimi, ASA; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Singh, SK; Bhatt, S; Chellappan, DK; Dua, K; Gupta, G |
| 2022-06 | Impact of ecDNA: A mechanism that directs tumorigenesis in cancer drug Resistance-A review | Ashique, S; Upadhyay, A; Garg, A; Mishra, N; Hussain, A; Negi, P; Hing, GB; Bhatt, S; Ali, MK; Gowthamarajan, K; Singh, SK; Gupta, G; Chellappan, DK; Dua, K |
| 2022-01-10 | Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseases. | Mishra, N; Ashique, S; Garg, A; Rai, VK; Dua, K; Goyal, A; Bhatt, S |
| 2022-02 | Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models | Tan, CL; Chan, Y; Candasamy, M; Chellian, J; Madheswaran, T; Sakthivel, LP; Patel, VK; Chakraborty, A; MacLoughlin, R; Kumar, D; Verma, N; Malyla, V; Gupta, PK; Jha, NK; Thangavelu, L; Devkota, HP; Bhatt, S; Prasher, P; Gupta, G; Gulati, M; Singh, SK; Paudel, KR; Hansbro, PM; Oliver, BG; Dua, K; Chellappan, DK |
| 2021-04 | Using Hawkes Processes to model imported and local malaria cases in near-elimination settings. | Unwin, HJT; Routledge, I; Flaxman, S; Rizoiu, M-A; Lai, S; Cohen, J; Weiss, DJ; Mishra, S; Bhatt, S |
